| ||
| November 16, 2010 Cerulean Raises $24M Series C, Heads Into Phase ... drug in Phase II trials of patients with non-small cell lung cancer. Cerulean's nanoparticle therapies are designed to enter the tumor and release a drug ... ceruleanrx.com/Press/DowJonesVentureWire_111610.pdf |
This once a day Google Alert is brought to you by Google.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment